Category Archives: Events
Spring 2012 Immunogenicity Workshop Schedule
Come participate in one of the following hands-on demonstrations of our bioinformatics tools! Each of these workshops features presentations and demonstrations led by our expert immunoinformaticians. Learn from the best! Hands-on Workshops! 5th Antibody Generation, Engineering & Design Conference Frankfurt, … Continue reading
Posted in Events, News
Leave a comment
Happy New Year! Tregitope World Tour 2012
It’s a New Year (2012) and our resolution is to keep you better informed. Here’s a list of our upcoming conferences. . . . Continue reading
Posted in Events, News
Leave a comment
Westin Immunogenicity Seminar September 27 2011, Tokyo, Japan
Westin Immunogenicity Seminar 2011 Tuesday, September 27, 2011 9:45 am – 6:10 pm Kiri Room The Westin Tokyo 1-4-1 Mita Meguro-ku, Tokyo 153-8580 Japan Speakers: Annie De Groot M.D. Director and Professor, Institute of Immunology and Informatics,University of Rhode Island … Continue reading
Tregitope World Tour 2011
Tregitope offers an opportunity to rethink protein therapeutics, immunogenicity and tolerance. Evidence is accumulating that Tregitopes are the ‘natural off switch’, leading to suppression of inflammatory T cell responses, and modulating the phenotype of antigen presenting cells. Learn more about Tregitope by participating in the following conferences where the collective work of the Tregitope researchers will be presented . . . Continue reading
Posted in Blog, Events
4 Comments
Immunogenicity and Vaccine Talks 2011
Come hear the latest updates on better proteins and vaccines by design – See our list of speaking engagements and appearances here: Continue reading
Posted in Events, News
Tagged Biologics, biotech, Conference, Conferences, Immunogenicity, Tregitope, Tregitopes, Vaccine
Leave a comment
Immunogenicity: Determinants and Correlates
A ‘don’t-miss’ meeting of academic researchers, immunologists, and industry scientists gathering to discuss in silico, in vitro and in vivo drivers of human immune response. The meeting is followed by a hands-on training in immunoinformatics (TRIAD Toolkit) and the annual Tregitope meeting (discussion of tolerance-inducing Tregitope). Continue reading
Posted in Blog, Events
Tagged Biologics, biotech, Conference, Conferences, Immunogenicity, Tolerance, Tregitope, Tregitopes, TRIAD
Comments Off
Agenda for Immunogenicity Determinants and Correlates Conference
Agenda for Immunogenicity Determinants and Correlates Conference – Valid as of March 05, 2011 Continue reading
Posted in Events, News
Tagged Biologics, biotech, Conference, iCubed, Immunogenicity, Tolerance, Tregitope, Tregitopes
1 Comment
4th Tregitope Update – Open Meeting May 11 2011
Tregitopes are small peptidic regulatory T-cell epitopes derived from human immunoglobulins that activate regulatory T cells (Tregs). Tregitope therapy has broad-reaching implications, offering new treatments for autoimmune diseases (e.g. type 1 juvenile diabetes, multiple sclerosis, rheumatoid arthritis, and lupus), allergies, and transplantation rejection. In previous meetings, the members of the Tregitope Collaborators team have demonstrated the immune suppressive capacity of Tregitopes. Ongoing research in the laboratories of the collaborators seeks to define the mechanism by which Tregitopes regulate immune responses and thereby accelerate the translation of this novel therapy to the clinic. Continue reading
Posted in Events, News
Tagged Biologics, Conference, Conferences, Tolerance, Tregitope, Tregitopes
2 Comments
Immunogenicity Determinants and Correlates: Registration Now Open
Immunogenicity: Determinants and Correlates is a non-commercial meeting, sponsored by the Institute for Immunology and Informatics and organized by individuals from a wide range of backgrounds including industry and academic settings. The current agenda, confirmed speakers, and the registration website are now posted for your review. Continue reading
Posted in Events, News
Tagged Biologics, Conference, Conferences, Immunogenicity, Tolerance, Tregitope, Tregitopes, TRIAD
1 Comment
Immunogenicity Seminar @ Westin Tokyo 2011
Expert immunologist and Biotech CEO Dr. Annie De Groot of EpiVax, Inc. who is also faculty member of the Brown University Medical School and Professor at the University of Rhode Island, will provide a detailed discussion of immunogenicity and tolerance for a highly selected audience. We will address the following important questions:
(1) What drives the immunogenicity problem for protein drugs?
(2) How can regulatory T cells be engaged to control immunogenicity through Tregitopes?
(3) What are the best means to predict and prevent immunogenicity? Continue reading
